Calidi Biotherapeutics Inc (CLDI)

$1.54 -0.04 (-2.53%)
Market Cap 5.28M
Revenue (ttm) 0.00
Net Income (ttm) -22.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.29
Volume 48,200
Avg Vol 209,362
Day's Range N/A - N/A
Shares Out 3.43M
Stochastic %K 46%
Beta 1.07
Analysts Sell
Price Target $120.05

Company Profile

Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States. Its product pipeline comprises CLD-101, which is in Phase 1b/2 clinical trial for the treatment of high-grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck squamous cell carcino...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 794 9600
Fax: 858 794 9605
Address:
4475 Executive Drive, Suite 200, San Diego, United States
race2zero
race2zero Oct. 31 at 8:06 PM
$CLDI another quality week put in by the biggest bio scam on the market 
0 · Reply
race2zero
race2zero Oct. 31 at 5:17 PM
$CLDI
0 · Reply
race2zero
race2zero Oct. 31 at 3:06 PM
$CLDI only 8K volume, however it is 4X the amount of shares rhe CFO has
1 · Reply
Turd19
Turd19 Oct. 31 at 1:59 PM
$CLDI what’s the Jsst on this stock? I bought in for a 1,000 shares because WeBull “strongly suggested it”. Is it possible for this to go wild and actually achieve $120 share price? If you’re going to post a stupid reply, just know that I already banged your mom and drank all your apple juice this morning.
2 · Reply
race2zero
race2zero Oct. 30 at 7:14 PM
$CLDI not sure if positive results will generate enough interest to have it the volume needed. Management had been completely silent since diluting the crap out of this when there was no volume to soften the blow a little. No trust, most likely just another bio scam trying to pretend to have a product in the works while just using reverse splits a dilution to pay themselves handsomely. In what world can you drive down the value of the stock over 99.80%, be nowhere near an actual revenue generating product and keep receiving a huge salary?
0 · Reply
uindicator
uindicator Oct. 30 at 6:58 PM
$CLDI what’s a realistic price target if say the latest results are promising, could they get an IND for redtail sooner?
2 · Reply
race2zero
race2zero Oct. 30 at 6:54 PM
$CLDI three month chart is very impressive. Management is legit!
0 · Reply
Pkinla
Pkinla Oct. 30 at 5:28 PM
$CLDI in the meantime Ints going bonkers today!
0 · Reply
Emaar
Emaar Oct. 30 at 2:09 PM
$CLDI added a starter here
0 · Reply
_SneakySwingg
_SneakySwingg Oct. 29 at 10:30 PM
BREAKING OUT! How much volume do you think it takes to gap ARBB up? ARBB has not even 900K shares float and recent news. Hoping for a 100% run on ARBB $SEAT $MKZR $CLDI $ACXP /
0 · Reply
Latest News on CLDI
Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option

Aug 21, 2025, 6:33 PM EDT - 2 months ago

Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option

Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering

Aug 20, 2025, 9:15 AM EDT - 2 months ago

Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering

Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

Aug 8, 2025, 4:15 PM EDT - 3 months ago

Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

Jul 25, 2025, 4:45 PM EDT - 3 months ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on July 24

Jul 22, 2025, 8:00 AM EDT - 3 months ago

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on July 24

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment

Jul 10, 2025, 8:30 AM EDT - 4 months ago

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment

Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds

Jul 9, 2025, 2:01 PM EDT - 4 months ago

Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment

Jul 8, 2025, 8:30 AM EDT - 4 months ago

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment

Calidi Biotherapeutics Announces Shareholder Letter from CEO

Jun 27, 2025, 8:00 AM EDT - 4 months ago

Calidi Biotherapeutics Announces Shareholder Letter from CEO

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

Apr 25, 2025, 8:00 AM EDT - 6 months ago

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

Global X Offers Precise U.S. Equity Exposure with Launch of Domestic Focused Funds

Apr 16, 2025, 9:30 AM EDT - 7 months ago

Global X Offers Precise U.S. Equity Exposure with Launch of Domestic Focused Funds

EGLE

Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Mar 31, 2025, 4:30 PM EDT - 7 months ago

Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Mar 28, 2025, 9:00 AM EDT - 7 months ago

Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform

Mar 10, 2025, 8:00 AM EDT - 8 months ago

Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform

Calidi Biotherapeutics and OS Therapies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Feb 28, 2025, 9:00 AM EST - 8 months ago

Calidi Biotherapeutics and OS Therapies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

OSTX

Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital

Feb 24, 2025, 8:00 AM EST - 8 months ago

Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on February 5

Jan 29, 2025, 8:00 AM EST - 9 months ago

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on February 5

Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement

Jan 28, 2025, 8:00 AM EST - 9 months ago

Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock

Jan 10, 2025, 4:30 PM EST - 10 months ago

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock

Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock

Jan 10, 2025, 8:30 AM EST - 10 months ago

Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock

Calidi Biotherapeutics Announces Proposed Public Offering

Jan 8, 2025, 4:01 PM EST - 10 months ago

Calidi Biotherapeutics Announces Proposed Public Offering

Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock

Nov 15, 2024, 4:05 PM EST - 1 year ago

Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock

Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock

Nov 14, 2024, 8:30 AM EST - 1 year ago

Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results

Nov 12, 2024, 5:29 PM EST - 1 year ago

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Oct 25, 2024, 9:00 AM EDT - 1 year ago

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

NXL

Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences

Oct 24, 2024, 8:30 AM EDT - 1 year ago

Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences

Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

Oct 23, 2024, 8:31 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)

Oct 18, 2024, 11:00 PM EDT - 1 year ago

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)

Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Oct 18, 2024, 8:45 AM EDT - 1 year ago

Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

GRRR

Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results

Aug 13, 2024, 5:37 PM EDT - 1 year ago

Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results

GreenPower Motor and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Aug 2, 2024, 9:00 AM EDT - 1 year ago

GreenPower Motor and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

GP

Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor

Jul 29, 2024, 9:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor

Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform

Jul 18, 2024, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform

Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board

Jul 16, 2024, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board

Calidi to Effect Reverse Stock Split

Jul 5, 2024, 4:15 PM EDT - 1 year ago

Calidi to Effect Reverse Stock Split

Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors

Jun 27, 2024, 7:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors

Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13

Jun 11, 2024, 4:05 PM EDT - 1 year ago

Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13

Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi's Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors

Jun 10, 2024, 7:00 AM EDT - 1 year ago

Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi's Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors

Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting

Jun 3, 2024, 7:00 AM EDT - 1 year ago

Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting

Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds

May 31, 2024, 8:51 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds

Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV

May 17, 2024, 9:00 AM EDT - 1 year ago

Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV

UMAC

Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results

May 14, 2024, 4:05 PM EDT - 1 year ago

Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results

Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting

May 1, 2024, 7:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on April 24

Apr 23, 2024, 7:00 AM EDT - 1 year ago

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on April 24

Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering

Apr 19, 2024, 4:05 PM EDT - 1 year ago

Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering

Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering

Apr 16, 2024, 8:31 AM EDT - 1 year ago

Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering

Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company's Novel Immunotherapies at the AACR Annual Meeting 2024

Apr 9, 2024, 7:00 AM EDT - 1 year ago

Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company's Novel Immunotherapies at the AACR Annual Meeting 2024

race2zero
race2zero Oct. 31 at 8:06 PM
$CLDI another quality week put in by the biggest bio scam on the market 
0 · Reply
race2zero
race2zero Oct. 31 at 5:17 PM
$CLDI
0 · Reply
race2zero
race2zero Oct. 31 at 3:06 PM
$CLDI only 8K volume, however it is 4X the amount of shares rhe CFO has
1 · Reply
Turd19
Turd19 Oct. 31 at 1:59 PM
$CLDI what’s the Jsst on this stock? I bought in for a 1,000 shares because WeBull “strongly suggested it”. Is it possible for this to go wild and actually achieve $120 share price? If you’re going to post a stupid reply, just know that I already banged your mom and drank all your apple juice this morning.
2 · Reply
race2zero
race2zero Oct. 30 at 7:14 PM
$CLDI not sure if positive results will generate enough interest to have it the volume needed. Management had been completely silent since diluting the crap out of this when there was no volume to soften the blow a little. No trust, most likely just another bio scam trying to pretend to have a product in the works while just using reverse splits a dilution to pay themselves handsomely. In what world can you drive down the value of the stock over 99.80%, be nowhere near an actual revenue generating product and keep receiving a huge salary?
0 · Reply
uindicator
uindicator Oct. 30 at 6:58 PM
$CLDI what’s a realistic price target if say the latest results are promising, could they get an IND for redtail sooner?
2 · Reply
race2zero
race2zero Oct. 30 at 6:54 PM
$CLDI three month chart is very impressive. Management is legit!
0 · Reply
Pkinla
Pkinla Oct. 30 at 5:28 PM
$CLDI in the meantime Ints going bonkers today!
0 · Reply
Emaar
Emaar Oct. 30 at 2:09 PM
$CLDI added a starter here
0 · Reply
_SneakySwingg
_SneakySwingg Oct. 29 at 10:30 PM
BREAKING OUT! How much volume do you think it takes to gap ARBB up? ARBB has not even 900K shares float and recent news. Hoping for a 100% run on ARBB $SEAT $MKZR $CLDI $ACXP /
0 · Reply
SayZero
SayZero Oct. 29 at 1:25 PM
$CLDI $GPUS But it just keeps going up on ya...You're not good at this at all. The losses you rack up. You spend more time spamming these boards of nonsense and make believe than trading. Maybe if you worried more about your money, than others, maybe you wouldn't lose more than you gain. Be well....Stop with the endless spamming....You're desperation shows....
1 · Reply
race2zero
race2zero Oct. 29 at 1:22 PM
$CLDI $GPUS living rent free in your head! I’m glad I can be a distraction as you watch all your money disappear
0 · Reply
SayZero
SayZero Oct. 29 at 1:18 PM
$CLDI $GPUS Ouch. You're not good at this market thingy! lol
1 · Reply
race2zero
race2zero Oct. 29 at 12:57 PM
$CLDI alright, nobody is here so I’ll be back when they start dropping this so they can reverse split and dilute again…it’s like a retirement plan.
0 · Reply
__AbnormalTrendz
__AbnormalTrendz Oct. 29 at 2:05 AM
Been noticing a pattern! when @Invinc1ble starts mentioning a stock rotation, it’s usually right before things start to move. Worth a follow 👍 $MKZR $CLDI $ACXP $NIVF Rosters+
0 · Reply
race2zero
race2zero Oct. 28 at 12:35 PM
$CLDI I wonder if those huge premarket buys were from the new advisory board members
0 · Reply
race2zero
race2zero Oct. 28 at 3:37 AM
$CLDI what is going to drive some volume to this? It’s just stuck in the mud
0 · Reply
MxPw
MxPw Oct. 27 at 5:43 PM
$CLDI 1 more week then go time
1 · Reply
chickenugget
chickenugget Oct. 26 at 6:51 PM
$CLDI I'm still here
0 · Reply
race2zero
race2zero Oct. 25 at 4:01 AM
$CLDI they are coming up on the end of the runway fast, almost out of money. Nowhere close to a revenue generating product. Will need another RS and dilution to pay themselves. Ask yourself, why have none of the new “expert” advisory board not purchased any shares at this “rock bottom” price?
0 · Reply
NetworkNewsWire
NetworkNewsWire Oct. 24 at 7:52 PM
New LED Therapy Kills Cancer Cells While Sparing Healthy Tissues $CLDI https://ibn.fm/2VLoN #biomedstocks #cancer
0 · Reply
uindicator
uindicator Oct. 24 at 2:15 PM
$CLDI what are the odds us 4-5 people in this stock here are aware of the potential this drug can cure cancer , or we’re just delusional and sucked into the facade Caldidi is painting here. Odds are we’re fucked lol
1 · Reply